Desensitization of G-protein-coupled receptors in the cardiovascular system. 1999

M Bünemann, and K B Lee, and R Pals-Rylaarsdam, and A G Roseberry, and M M Hosey
Department of Molecular Pharmacology & Biological Chemistry, Northwestern University Medical School, Chicago, Illinois 60611, USA.

Multiple mechanisms exist to control the signaling and density of G-protein-coupled receptors (GPRs). Upon agonist binding and receptor activation, a series of reactions participate in the turn off or desensitization of GPRs. Many GPRs are phosphorylated by protein kinases and consequently uncoupled from G proteins. In addition, many GPRs are sequestered from the cell surface and become inaccessible to their activating ligands. Both receptor:G protein uncoupling and receptor sequestration may involve the participation of arrestins or other proteins. A model for receptor regulation has been developed from studies of the beta-adrenergic receptor. However, recent studies suggest that other GPRs important in the cardiovascular system, such as the muscarinic cholinergic receptors that regulate heart rate, might be regulated by mechanisms other than those that regulate the beta-adrenergic receptors. This review summarizes our current understanding of the processes involved in the desensitization of GPRs.

UI MeSH Term Description Entries
D011956 Receptors, Cell Surface Cell surface proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell (From Alberts, Molecular Biology of the Cell, 2nd ed, pp693-5). Cell surface receptors, unlike enzymes, do not chemically alter their ligands. Cell Surface Receptor,Cell Surface Receptors,Hormone Receptors, Cell Surface,Receptors, Endogenous Substances,Cell Surface Hormone Receptors,Endogenous Substances Receptors,Receptor, Cell Surface,Surface Receptor, Cell
D002319 Cardiovascular System The HEART and the BLOOD VESSELS by which BLOOD is pumped and circulated through the body. Circulatory System,Cardiovascular Systems,Circulatory Systems
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D019204 GTP-Binding Proteins Regulatory proteins that act as molecular switches. They control a wide range of biological processes including: receptor signaling, intracellular signal transduction pathways, and protein synthesis. Their activity is regulated by factors that control their ability to bind to and hydrolyze GTP to GDP. EC 3.6.1.-. G-Proteins,GTP-Regulatory Proteins,Guanine Nucleotide Regulatory Proteins,G-Protein,GTP-Binding Protein,GTP-Regulatory Protein,Guanine Nucleotide Coupling Protein,G Protein,G Proteins,GTP Binding Protein,GTP Binding Proteins,GTP Regulatory Protein,GTP Regulatory Proteins,Protein, GTP-Binding,Protein, GTP-Regulatory,Proteins, GTP-Binding,Proteins, GTP-Regulatory
D020794 Receptor Protein-Tyrosine Kinases A class of cellular receptors that have an intrinsic PROTEIN-TYROSINE KINASE activity. PTK Receptor,Receptors, Protein-Tyrosine Kinase,Tyrosine Kinase Linked Receptor,Tyrosine Kinase Linked Receptors,Tyrosine Kinase Receptor,Tyrosine Kinase Receptors,PTK Receptors,Protein-Tyrosine Kinase Receptor,Receptor Protein-Tyrosine Kinase,Kinase Receptor, Tyrosine,Kinase, Receptor Protein-Tyrosine,Kinases, Receptor Protein-Tyrosine,Protein-Tyrosine Kinase Receptors,Protein-Tyrosine Kinase, Receptor,Protein-Tyrosine Kinases, Receptor,Receptor Protein Tyrosine Kinase,Receptor Protein Tyrosine Kinases,Receptor, PTK,Receptor, Protein-Tyrosine Kinase,Receptor, Tyrosine Kinase,Receptors, PTK,Receptors, Protein Tyrosine Kinase

Related Publications

M Bünemann, and K B Lee, and R Pals-Rylaarsdam, and A G Roseberry, and M M Hosey
January 1996, Recent progress in hormone research,
M Bünemann, and K B Lee, and R Pals-Rylaarsdam, and A G Roseberry, and M M Hosey
October 2002, Science's STKE : signal transduction knowledge environment,
M Bünemann, and K B Lee, and R Pals-Rylaarsdam, and A G Roseberry, and M M Hosey
January 2008, Life sciences,
M Bünemann, and K B Lee, and R Pals-Rylaarsdam, and A G Roseberry, and M M Hosey
January 2004, Annual review of neuroscience,
M Bünemann, and K B Lee, and R Pals-Rylaarsdam, and A G Roseberry, and M M Hosey
April 2021, Archives of pharmacal research,
M Bünemann, and K B Lee, and R Pals-Rylaarsdam, and A G Roseberry, and M M Hosey
January 2006, Biochemical and biophysical research communications,
M Bünemann, and K B Lee, and R Pals-Rylaarsdam, and A G Roseberry, and M M Hosey
January 2003, Trends in pharmacological sciences,
M Bünemann, and K B Lee, and R Pals-Rylaarsdam, and A G Roseberry, and M M Hosey
April 2018, Journal of cardiovascular pharmacology,
M Bünemann, and K B Lee, and R Pals-Rylaarsdam, and A G Roseberry, and M M Hosey
January 2005, Experimental and clinical cardiology,
M Bünemann, and K B Lee, and R Pals-Rylaarsdam, and A G Roseberry, and M M Hosey
January 2002, Methods in enzymology,
Copied contents to your clipboard!